0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
The Covaxin Phase 3 trial has shown a result of 77.8 percent efficacy according to new reports. Covaxin is one of the three COVID vaccines currently approved and used in India.
Share this article
If you liked this article share it with your friends.they will thank you later